Virtu Financial »

Taysha Gene Therapies shares owned by Virtu Financial

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $46k 26k 1.76
2023-03-31 $36k 46k 0.79

More positions owned by Virtu Financial

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Technology (XLK)
Meta Platforms Cl A (META)
Direxion Shs Etf Tr Drx S P500bull (SPXL)
Direxion Shs Etf Tr 20yr Tres Bear (TMV)
Vanguard Index Fds S P 500 Etf Shs (VOO)
Select Sector Spdr Tr Financial (XLF)
Synopsys (SNPS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Altria (MO)
Hess (HES)
Pfizer (PFE)
News Corp Cl A (NWSA)
Invesco Currencyshares Cdn D CDN DLR SHS (FXC)

View all positions for Virtu Financial

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
T. Rowe Price Associates
Schonfeld Strategic Advisors
Exome Asset Management
Alphabet
Quantum Private Wealth
Palo Alto Investors

View all funds holding Taysha Gene Therapies